Your browser doesn't support javascript.
loading
Dynamic transcriptional reprogramming leads to immunotherapeutic vulnerabilities in myeloma.
Frede, Julia; Anand, Praveen; Sotudeh, Noori; Pinto, Ricardo A; Nair, Monica S; Stuart, Hannah; Yee, Andrew J; Vijaykumar, Tushara; Waldschmidt, Johannes M; Potdar, Sayalee; Kloeber, Jake A; Kokkalis, Antonis; Dimitrova, Valeriya; Mann, Mason; Laubach, Jacob P; Richardson, Paul G; Anderson, Kenneth C; Raje, Noopur S; Knoechel, Birgit; Lohr, Jens G.
Afiliación
  • Frede J; Department of Medical Oncology, Jerome Lipper Multiple Myeloma Center, Dana Farber Cancer Institute, Boston, MA, USA.
  • Anand P; Harvard Medical School, Boston, MA, USA.
  • Sotudeh N; Broad Institute of MIT and Harvard, Cambridge, MA, USA.
  • Pinto RA; Department of Medical Oncology, Jerome Lipper Multiple Myeloma Center, Dana Farber Cancer Institute, Boston, MA, USA.
  • Nair MS; Harvard Medical School, Boston, MA, USA.
  • Stuart H; Broad Institute of MIT and Harvard, Cambridge, MA, USA.
  • Yee AJ; Department of Medical Oncology, Jerome Lipper Multiple Myeloma Center, Dana Farber Cancer Institute, Boston, MA, USA.
  • Vijaykumar T; Harvard Medical School, Boston, MA, USA.
  • Waldschmidt JM; Broad Institute of MIT and Harvard, Cambridge, MA, USA.
  • Potdar S; Broad Institute of MIT and Harvard, Cambridge, MA, USA.
  • Kloeber JA; Department of Data Sciences, Dana-Farber Cancer Institute, Boston, MA, USA.
  • Kokkalis A; Department of Biomedical Informatics, Harvard Medical School, Boston, MA, USA.
  • Dimitrova V; Department of Medical Oncology, Jerome Lipper Multiple Myeloma Center, Dana Farber Cancer Institute, Boston, MA, USA.
  • Mann M; Department of Medical Oncology, Jerome Lipper Multiple Myeloma Center, Dana Farber Cancer Institute, Boston, MA, USA.
  • Laubach JP; Harvard Medical School, Boston, MA, USA.
  • Richardson PG; Massachusetts General Hospital, Boston, MA, USA.
  • Anderson KC; Department of Medical Oncology, Jerome Lipper Multiple Myeloma Center, Dana Farber Cancer Institute, Boston, MA, USA.
  • Raje NS; Department of Medical Oncology, Jerome Lipper Multiple Myeloma Center, Dana Farber Cancer Institute, Boston, MA, USA.
  • Knoechel B; Harvard Medical School, Boston, MA, USA.
  • Lohr JG; Broad Institute of MIT and Harvard, Cambridge, MA, USA.
Nat Cell Biol ; 23(11): 1199-1211, 2021 11.
Article en En | MEDLINE | ID: mdl-34675390
Asunto(s)
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Transcripción Genética / Resistencia a Antineoplásicos / Receptores CXCR4 / Reprogramación Celular / Inmunoterapia / Mieloma Múltiple / Antineoplásicos Límite: Aged / Aged80 / Female / Humans / Male / Middle aged Idioma: En Revista: Nat Cell Biol Año: 2021 Tipo del documento: Article País de afiliación: Estados Unidos Pais de publicación: Reino Unido
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Transcripción Genética / Resistencia a Antineoplásicos / Receptores CXCR4 / Reprogramación Celular / Inmunoterapia / Mieloma Múltiple / Antineoplásicos Límite: Aged / Aged80 / Female / Humans / Male / Middle aged Idioma: En Revista: Nat Cell Biol Año: 2021 Tipo del documento: Article País de afiliación: Estados Unidos Pais de publicación: Reino Unido